BGI opens European research centre
BGI has opened its first European genome research centre, which is located in Copenhagen Bio Science Park (COBIS).
BGI has opened its first European genome research centre, which is located in Copenhagen Bio Science Park (COBIS). The centre is a collaboration between BGI and Danish research institutes, including the University of Copenhagen.
The centre plans to establish collaborations in Europe to develop genomics research and applications in healthcare, agriculture and bioenergy.
Ning Li, Director of BGI Europe, commented, “Our primary mission of this research centre is to provide BGI’s world-class expertise and infrastructure for the European researchers in genomics, proteomics, bioinformatics and other related areas. The opening of the genome research centre will add immense value on science advancement and application for both BGI Europe and Denmark.”
Thomas Bjørnholm, vice chancellor of the University of Copenhagen, said, “Both the facilities and the Danish and international scientists behind the centre are state-of-the-art. The vision is to create the best facilities in the fields of genomics and bioinformatics, so that we have an opportunity to use knowledge on genomics and better Denmark’s possibilities of preventing and curing diseases. For example, we hope that it will be possible to develop a vaccine for cancer.”
For more information please visit ref="http://www.genomics.cn">www.genomics.cn
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
